Cytek Biosciences (CTKB) Metrics: History & Chart

Cytek Biosciences, Inc.(CTKB)

Medical - Devices · Fremont, CA

$5.98-0.11 (-1.81%)

Delayed quote: Oct 6, 2026, 10:00 AM EDT

About Cytek Biosciences, Inc.

Cytek Biosciences, Inc. is a company dedicated to cell analysis solutions, offering advanced tools that facilitate scientific progress in both biomedical research and clinical settings. Their primary offerings include the Aurora and Northern Lights spectrum flow cytometers. These instruments conduct comprehensive cell analysis by leveraging fluorescence signatures from multiple lasers to differentiate between various fluorescent tags on individual cells. Complementing these, the Aurora Cell Sorter system utilizes full spectrum profiling technology to broaden the range of potential applications in cell analysis. Beyond instrumentation, Cytek provides essential reagents and kits. These include cFluor reagents, which are antibodies conjugated with fluorochromes, specifically designed to identify target cells for analysis on their systems. They also offer a 25-color immunoprofiling assay, a ready-to-use solution for pinpointing major human immune cell subpopulations like TBNK cells, monocytes, dendritic cells, and basophils. To streamline laboratory operations, the company offers automated micro-sampling and sample loader systems. These automated plate loaders are engineered to integrate seamlessly with the Aurora and Northern Lights systems. The intuitive SpectroFlo software accompanies these systems, simplifying the workflow from quality control through to data analysis. Cytek also provides comprehensive customer support resources. Cytek's diverse client base includes pharmaceutical and biopharmaceutical companies, academic research institutions, and clinical research organizations. The company distributes its products through a direct sales force and dedicated support teams in North America, Europe, China, and the Asia-Pacific region. Additionally, it partners with distributors and sales agents to serve markets across European, Latin American, Middle Eastern, and other Asia-Pacific countries. Originally established in 1992 as Cytoville, Inc., the company officially adopted the name Cytek Biosciences, Inc. in August 2015. Its corporate headquarters are situated in Fremont, California.

Fremont, CA

682 employees

cytekbio.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Wenbin Jiang

View full financials

Third-Party DCF Estimate (FMP)	$1.01
Price Gap vs Third-Party Estimate	-83.47%

7D Total Return	+6.10%
30D Total Return	+29.57%
YTD Total Return	+20.59%
1Y Total Return	+53.40%
3Y Total Return	+11.94%
5Y Total Return	-73.21%
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	+20.59%
2025	-22.19%
2024	-28.84%
2023	-10.68%
2022	-37.44%
2021	N/A
2020

CAGR TTM	+53.09%
CAGR 3Y	+3.83%
CAGR 5Y	-23.16%
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	674.57
PE Ratio Avg TTM	991.02
PE Ratio Avg 3Y	328.78
Current VS TTM Avg	-31.93%
Current VS 3Y Avg	+105.17%
Current VS 5Y Avg	+105.17%

All Metrics

CTKB Valuation Metrics

CTKB Stock Price Metrics

CTKB Dividend Metrics

CTKB Growth Rate Metrics

CTKB Discounted Cash Flow Metrics

CTKB Returns By Period

CTKB Yearly Returns

CTKB Average Annual Returns By Period (CAGR)

CTKB Revenue Metrics

CTKB PE Ratio Metrics

CTKB PS Ratio Metrics

CTKB PB Ratio Metrics

CTKB Price to Free Cash Flow Ratio Metrics

CTKB Debt to Equity Ratio Metrics

CTKB PEG Ratio Metrics

CTKB FCF Yield

CTKB Earnings Yield

CTKB EBITDA Yield

CTKB OCF Yield

CTKB EV/EBIT Ratio Metrics

CTKB EV/EBITDA Ratio Metrics

CTKB EV/Assets Ratio Metrics

CTKB EV/Sales Ratio Metrics

CTKB Current Ratio Metrics

CTKB Quick Ratio Metrics

CTKB ROIC Metrics

CTKB Return on Assets Metrics

CTKB Return on Equity Metrics

CTKB Net Profit Margin Metrics

CTKB Gross Profit Margin Metrics

CTKB Tax Rate Metrics

PS Ratio	3.81
PS Ratio Avg TTM	2.95
PS Ratio Avg 3Y	3.29
Current VS TTM Avg	+29.26%
Current VS 3Y Avg	+15.72%
Current VS 5Y Avg	-37.59%

PB Ratio	2.45
PB Ratio Avg TTM	1.68
PB Ratio Avg 3Y	1.77
Current VS TTM Avg	+46.24%
Current VS 3Y Avg	+38.78%
Current VS 5Y Avg	-0.10%

PFCF Ratio	46.01
PFCF Ratio Avg TTM	30.58
PFCF Ratio Avg 3Y	37.70
Current VS TTM Avg	+50.48%
Current VS 3Y Avg	+22.05%
Current VS 5Y Avg	-71.82%

Debt/Equity Ratio	0.08
Debt/Equity Ratio Avg TTM	0.08
Debt/Equity Ratio Avg 3Y	0.06
Current VS TTM Avg	-1.72%
Current VS 3Y Avg	+47.63%
Current VS 5Y Avg	+113.94%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	2.17%
FCF Yield Avg TTM	3.52%
FCF Yield Avg 3Y	2.41%
Current VS TTM Avg	-38.43%
Current VS 3Y Avg	-9.79%
Current VS 5Y Avg	+25.93%

Earnings Yield	0.15%
Earnings Yield Avg TTM	0.12%
Earnings Yield Avg 3Y	0.36%
Current VS TTM Avg	+21.30%
Current VS 3Y Avg	-58.68%
Current VS 5Y Avg	-58.68%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	1559.29
Ev/Ebit Ratio Avg TTM	501.20
Ev/Ebit Ratio Avg 3Y	137.25
Current VS TTM Avg	+211.11%
Current VS 3Y Avg	+1036.13%
Current VS 5Y Avg	+1036.13%

Ev/Ebitda Ratio	416.98
Ev/Ebitda Ratio Avg TTM	316.20
Ev/Ebitda Ratio Avg 3Y	225.87
Current VS TTM Avg	+31.87%
Current VS 3Y Avg	+84.61%
Current VS 5Y Avg	+84.61%

Ev/Assets Ratio	1.66
Ev/Assets Ratio Avg TTM	1.14
Ev/Assets Ratio Avg 3Y	1.14
Current VS TTM Avg	+45.58%
Current VS 3Y Avg	+45.25%
Current VS 5Y Avg	+1.54%

Ev/Sales Ratio	3.58
Ev/Sales Ratio Avg TTM	2.68
Ev/Sales Ratio Avg 3Y	2.75
Current VS TTM Avg	+33.80%
Current VS 3Y Avg	+30.20%
Current VS 5Y Avg	-26.26%

Current Ratio	4.48
Current Ratio Avg TTM	4.92
Current Ratio Avg 3Y	6.05
Current VS TTM Avg	-8.90%
Current VS 3Y Avg	-25.99%
Current VS 5Y Avg	-42.01%

Quick Ratio	3.86
Quick Ratio Avg TTM	4.28
Quick Ratio Avg 3Y	5.23
Current VS TTM Avg	-9.68%
Current VS 3Y Avg	-26.22%
Current VS 5Y Avg	-40.45%

ROIC	(12.00%)
ROIC Avg 3Y	(5.83%)
ROIC Avg 5Y	(3.92%)
Current VS 3Y Avg	-105.87%
Current VS 5Y Avg	-205.79%
Current VS 10Y Avg	-307.86%

ROA	(18.03%)
ROA Avg TTM	(3.74%)
ROA Avg 3Y	(1.43%)
Current VS TTM Avg	-381.85%
Current VS 3Y Avg	-1162.68%
Current VS 5Y Avg	-3630.58%

ROE	(25.03%)
ROE Avg TTM	(14.43%)
ROE Avg 3Y	(2.75%)
Current VS TTM Avg	-73.42%
Current VS 3Y Avg	-808.55%
Current VS 5Y Avg	-1590.21%

Net Profit Margin	(38.98%)
Net Profit Margin Avg TTM	(32.33%)
Net Profit Margin Avg 3Y	(15.03%)
Current VS TTM Avg	-20.57%
Current VS 3Y Avg	-159.30%
Current VS 5Y Avg	-409.80%

Gross Profit Margin	53.23%
Gross Pft Margin Avg TTM	52.99%
Gross Pft Margin Avg 3Y	54.18%
Current VS TTM Avg	+0.45%
Current VS 3Y Avg	-1.76%
Current VS 5Y Avg	-6.42%

Tax Rate	6.59%
Tax Rate Avg 3Y	(23.75%)
Tax Rate Avg 5Y	(2.23%)
Current VS 3Y Avg	+127.73%
Current VS 5Y Avg	+394.86%
Current VS 10Y Avg	+394.86%